Ketamine Trial Aims to Blunt Depression, Craving and Relapse in Opioid Use Disorder
A phase II randomised, double-blind, placebo-controlled trial in Cyprus will test whether six intravenous ketamine infusions can reduce depressive symptoms, ...
A phase II randomised, double-blind, placebo-controlled trial in Cyprus will test whether six intravenous ketamine infusions can reduce depressive symptoms, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine